133 related articles for article (PubMed ID: 9834823)
1. An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Degardin M; Oliveira J; Geoffrois L; Rolland F; Armand JP; Bastit P; Chauvergne J; Fargeot P; van Glabbeke M; Lentz MA; Tresca P; Boudillet J; Fumoleau P; Cappelaere P
Ann Oncol; 1998 Oct; 9(10):1103-7. PubMed ID: 9834823
[TBL] [Abstract][Full Text] [Related]
2. A phase II trial of vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Saxman S; Mann B; Canfield V; Loehrer P; Vokes E
Am J Clin Oncol; 1998 Aug; 21(4):398-400. PubMed ID: 9708641
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group.
Schöffski P; Catimel G; Planting AS; Droz JP; Verweij J; Schrijvers D; Gras L; Schrijvers A; Wanders J; Hanauske AR
Ann Oncol; 1999 Jan; 10(1):119-22. PubMed ID: 10076732
[TBL] [Abstract][Full Text] [Related]
4. Treatment of recurrent and/or metastatic squamous cell head and neck carcinoma with a combination of vinorelbine, cisplatin, and 5-fluorouracil: a multicenter phase II trial.
Gebbia V; Mantovani G; Agostara B; Contu A; Farris A; Colucci G; Cognetti F; Restivo G; Speciale R; Ferrero B
Ann Oncol; 1995 Dec; 6(10):987-91. PubMed ID: 8750150
[TBL] [Abstract][Full Text] [Related]
5. Vinorelbine in pre-treated advanced head & neck squamous cell carcinoma. A phase II study.
Testolin A; Recher G; Cristoferi V; Gasparini G
Invest New Drugs; 1994; 12(3):231-4. PubMed ID: 7896542
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma.
Shin DM; Khuri FR; Glisson BS; Ginsberg L; Papadimitrakopoulou VM; Clayman G; Lee JJ; Ang KK; Lippman SM; Hong WK
Cancer; 2001 Apr; 91(7):1316-23. PubMed ID: 11283932
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of vinorelbine in heavily pretreated recurrent/metastatic head and neck squamous cell carcinoma patients.
Barth C; Naveau L; Touboul E; Périé S; Bamogho E; Haberer-Guillerm S; Schlienger M; Lacau St Guily J; Huguet F
Anticancer Drugs; 2016 Apr; 27(4):349-52. PubMed ID: 26736136
[TBL] [Abstract][Full Text] [Related]
8. Vinorelbine plus cisplatin in recurrent or previously untreated unresectable squamous cell carcinoma of the head and neck.
Gebbia V; Testa A; Di Gregorio C; Ingria F; Valenza R; Cannata G; Moschella F; Restivo G; Gebbia N
Am J Clin Oncol; 1995 Aug; 18(4):293-6. PubMed ID: 7625368
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of single-agent oral vinorelbine in patients with pretreated advanced non-small-cell lung cancer.
Rossi D; Catalano V; Alessandroni P; Fedeli A; Fedeli SL; Giordani P; Baldelli AM; Casadei V; Ceccolini M; Ugolini M; Dennetta D; Catalano G
Clin Lung Cancer; 2007 May; 8(6):382-5. PubMed ID: 17562239
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of vinorelbine/cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck progressing after at least two chemotherapy regimens.
Massa E; Dessì M; Gaspardini G; Saba F; Cherchi V; Mantovani G
Oral Oncol; 2010 Nov; 46(11):818-21. PubMed ID: 20920877
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck.
Specht L; Larsen SK; Hansen HS
Ann Oncol; 2000 Jul; 11(7):845-9. PubMed ID: 10997812
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.
Catimel G; Verweij J; Mattijssen V; Hanauske A; Piccart M; Wanders J; Franklin H; Le Bail N; Clavel M; Kaye SB
Ann Oncol; 1994 Jul; 5(6):533-7. PubMed ID: 7918125
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group.
Conroy T; Etienne PL; Adenis A; Wagener DJ; Paillot B; François E; Bedenne L; Jacob JH; Seitz JF; Bleiberg H; Van Pottelsberghe C; Van Glabbeke M; Delgado FM; Merle S; Wils J
J Clin Oncol; 1996 Jan; 14(1):164-70. PubMed ID: 8558192
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study.
Lhommé C; Vermorken JB; Mickiewicz E; Chevalier B; Alvarez A; Mendiola C; Pawinski A; Lentz MA; Pecorelli S
Eur J Cancer; 2000 Jan; 36(2):194-9. PubMed ID: 10741277
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix.
Morris M; Brader KR; Levenback C; Burke TW; Atkinson EN; Scott WR; Gershenson DM
J Clin Oncol; 1998 Mar; 16(3):1094-8. PubMed ID: 9508195
[TBL] [Abstract][Full Text] [Related]
16. Vinorelbine, bleomycin and methotrexate as a salvage therapy for patients with head and neck squamous carcinoma in relapse after cisplatin/fluorouracil.
Iop A; Cartei G; Isaia A
Ann Oncol; 1998 Feb; 9(2):225-7. PubMed ID: 9553671
[TBL] [Abstract][Full Text] [Related]
17. Phase II evaluation of 96-hour paclitaxel infusion in advanced (recurrent or metastatic) squamous cell carcinoma of the head and neck (E3395): a trial of the Eastern Cooperative Oncology Group.
Langer CJ; Li Y; Jennings T; DeConti RC; Nair S; Cohen RB; Forastiere AA;
Cancer Invest; 2004; 22(6):823-31. PubMed ID: 15641479
[TBL] [Abstract][Full Text] [Related]
18. Vinorelbine, cisplatin, and 5-fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck: results of a phase II multicenter study.
Gebbia V; Mantovani G; Farris A; Agostara B; Desogus A; Curreli L; Moschella F; Di Gregorio C; Bajetta E; Gebbia N
Cancer; 1997 Apr; 79(7):1394-400. PubMed ID: 9083162
[TBL] [Abstract][Full Text] [Related]
19. Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Hitt R; Amador ML; Quintela-Fandino M; Jimeno A; del Val O; Hernando S; Cortes-Funes H
Cancer; 2006 Jan; 106(1):106-11. PubMed ID: 16329139
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel: an active drug for squamous cell carcinoma of the head and neck.
Dreyfuss AI; Clark JR; Norris CM; Rossi RM; Lucarini JW; Busse PM; Poulin MD; Thornhill L; Costello R; Posner MR
J Clin Oncol; 1996 May; 14(5):1672-8. PubMed ID: 8622087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
